Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priyanka Arora

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2025
Pharmacokinetics and Safety of Bictegravir in Pregnant and Postpartum Persons With HIV and Their InfantsKathleen M Powis, Mauricio Pinilla, Flynn McMorrow, et al.
Science Advances|February 11, 2021
Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancerNicole Oatman, Nupur Dasgupta, Priyanka Arora, et al.
The Lancet. HIV|July 13, 2026
HIV acquisitions, safety, and pharmacokinetics of lenacapavir for HIV pre-exposure prophylaxis in pregnant and lactating women (PURPOSE 1): a substudy of a phase 3, randomised controlled trialLinda-Gail Bekker, Dhayendre Moodley, Dazon Dixon Diallo, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2025
Pharmacokinetics and Safety of Bictegravir in Pregnant and Postpartum Persons With HIV and Their InfantsKathleen M Powis, Mauricio Pinilla, Flynn McMorrow, et al.
Science Advances|February 11, 2021
Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancerNicole Oatman, Nupur Dasgupta, Priyanka Arora, et al.
The Lancet. HIV|July 13, 2026
HIV acquisitions, safety, and pharmacokinetics of lenacapavir for HIV pre-exposure prophylaxis in pregnant and lactating women (PURPOSE 1): a substudy of a phase 3, randomised controlled trialLinda-Gail Bekker, Dhayendre Moodley, Dazon Dixon Diallo, et al.
Pageof 5